Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 121

    1.

    Preclinical trauma studies of recombinant factor VIIa.

    Schreiber MA, Holcomb JB, Rojkjaer R.

    Crit Care. 2005;9 Suppl 5:S25-8. Epub 2005 Oct 7. Review.PMID: 16221316 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.

    Martinowitz U, Holcomb JB, Pusateri AE, Stein M, Onaca N, Freidman M, Macaitis JM, Castel D, Hedner U, Hess JR.

    J Trauma. 2001 Apr;50(4):721-9.PMID: 11303171 [PubMed - indexed for MEDLINE]Related articles

    3.

    Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.

    Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM.

    J Thromb Haemost. 2007 Feb;5(2):244-9. Epub 2006 Nov 27.PMID: 17129221 [PubMed - indexed for MEDLINE]Related articles

    4.

    Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.

    Mohr AM, Holcomb JB, Dutton RP, Duranteau J.

    Crit Care. 2005;9 Suppl 5:S37-42. Epub 2005 Oct 7. Review.PMID: 16221318 [PubMed - indexed for MEDLINE]Related articles

    5.

    Recombinant-activated coagulation factor VIIa (NovoSeven): current development.

    Weiskopf RB.

    Vox Sang. 2007 May;92(4):281-8. Review.PMID: 17456151 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.

    Sapsford W, Watts S, Cooper G, Kirkman E.

    J Trauma. 2007 Apr;62(4):868-79.PMID: 17426541 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of recombinant FVIIa in hypothermic, coagulopathic pigs with liver injuries.

    Klemcke HG, Delgado A, Holcomb JB, Ryan KL, Burke A, DeGuzman R, Scherer M, Cortez D, Uscilowicz J, Macaitis JM, Bliss J, Wojtaszczyk J, Christensen S, Currier H, Pusateri AE.

    J Trauma. 2005 Jul;59(1):155-61; discussion 161.PMID: 16096556 [PubMed - indexed for MEDLINE]Related articles

    8.

    Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.

    Tranholm M, Rojkjaer R, Pyke C, Kristensen AT, Klitgaard B, Lollike K, Blajchman MA.

    Thromb Res. 2003 Feb 15;109(4):217-23.PMID: 12757777 [PubMed - indexed for MEDLINE]Related articles

    9.

    Safety profile of recombinant factor VIIa.

    Roberts HR, Monroe DM 3rd, Hoffman M.

    Semin Hematol. 2004 Jan;41(1 Suppl 1):101-8. Review.PMID: 14872430 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recombinant activated coagulation factor VII and bleeding trauma patients.

    Rizoli SB, Nascimento B Jr, Osman F, Netto FS, Kiss A, Callum J, Brenneman FD, Tremblay L, Tien HC.

    J Trauma. 2006 Dec;61(6):1419-25.PMID: 17159685 [PubMed - indexed for MEDLINE]Related articles

    11.

    Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.

    Grounds M.

    Blood Rev. 2003 Sep;17 Suppl 1:S11-21. Review.PMID: 14697209 [PubMed - indexed for MEDLINE]Related articles

    12.

    Recombinant activated factor VII (rFVIIa, NovoSeven).

    Agarwal MB, Patnaik M.

    J Assoc Physicians India. 2005 Aug;53:717-20. Review.PMID: 16398083 [PubMed - indexed for MEDLINE]Related articles

    13.

    The emerging role of recombinant-activated factor VII in neurocritical care.

    Fewel ME, Park P.

    Neurocrit Care. 2004;1(1):19-29. Review.PMID: 16174895 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine.

    Pusateri AE, Ryan KL, Delgado AV, Martinez RS, Uscilowicz JM, Cortez DS, Martinowitz U.

    Thromb Haemost. 2005 Feb;93(2):275-83.PMID: 15711743 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation.

    Dickneite G.

    Thromb Res. 2007;119(5):643-51. Epub 2006 Jul 13.PMID: 16842841 [PubMed - indexed for MEDLINE]Related articles

    16.

    Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma.

    Holcomb JB.

    J Trauma. 2005 Jun;58(6):1298-303. Review.PMID: 15995488 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.

    Zhang J, Groff RF 4th, Chen XH, Browne KD, Huang J, Schwartz ED, Meaney DF, Johnson VE, Stein SC, Rojkjaer R, Smith DH.

    Exp Neurol. 2008 Apr;210(2):645-55. Epub 2008 Jan 5.PMID: 18291370 [PubMed - indexed for MEDLINE]Related articles

    18.

    Recombinant factor VIIa and the surgical patient.

    Scarpelini S, Rizoli S.

    Curr Opin Crit Care. 2006 Aug;12(4):351-6. Review.PMID: 16810047 [PubMed - indexed for MEDLINE]Related articles

    19.

    Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.

    Brenner B, Wiis J.

    Hematology. 2007 Feb;12(1):55-62.PMID: 17364994 [PubMed - indexed for MEDLINE]Related articles

    20.

    Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.

    Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ.

    Transfusion. 2006 Jun;46(6):919-33.PMID: 16734808 [PubMed - indexed for MEDLINE]Related articles